Research & Education

Molecular Testing for Non-small Cell Lung Cancer: EGFR and ALK TKI therapy in advanced NSCLC

At the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, experts in molecular testing gathered to discuss critical questions in molecular testing for non-small cell lung cancer. In this segment, Dr. Paul Bunn covers molecular basis including when and why to stop or change course.